AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

169.700

+2.6001.56%

Volume:159.44K

Turnover:26.86M

Market Cap:81.27B

PE:-22.67

High:169.910

Open:166.470

Low:166.430

Close:167.100

52wk High:216.752

52wk Low:88.837

Shares:478.91M

Float Shares:478.91M

Volume Ratio:0.92

T/O Rate:0.03%

Dividend:4.09

Dividend Rate:2.41%

EPS(TTM):-7.486

EPS(LYR):-7.486

ROE:-15.83%

ROA:7.26%

PB:3.93

PE(LYR):-22.67

Loading ...

Overview Company News Filings

CitiFirst CSL Instalments Dividend Final Amount-CTW

CSL Seqirus Publishes Phase 3 Study Results for Influenza Vaccine

MT Newswires Live

Australia's CSL Slips on Trading Ex-Dividend, Among Benchmark's Top Percentage Losers

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

CSL Says Vanguard Group Raises Stake

MT Newswires Live

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

Black Box Warning on CSL's Injectafer Unlikely to Change Much

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

CSL's U.S. Agreements Remove Two Stock Overhangs

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":169.7,"timestamp":1789347863523,"preClose":167.1,"halted":0,"volume":159436,"delay":0,"changeRate":0.0155595451825254,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.485836377806663,"marketStatus":"Trading","change":2.6,"latestTime":"09-14 11:04:29 AEST","open":166.47,"high":169.91,"low":166.43,"amount":26861713,"amplitude":0.020826,"askPrice":169.72,"askSize":9,"bidPrice":169.69,"bidSize":35,"shortable":3,"etf":0,"ttmEps":-7.485836377806663,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789365600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":167.1,"dividendRate":0.024012,"openAndCloseTimeList":[[1789344000000,1789365600000]],"volumeRatio":0.921085,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":167.1,"auctionPrice":166.47,"auctionVolume":18997,"auctionTime":1789343952637,"referenceTime":1789122603091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789343952637}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.485836,"volumeRatio":0.921085,"shares":478911979,"dividePrice":4.085728,"high":169.91,"amplitude":0.020826,"preClose":167.1,"low":166.43,"week52Low":88.837,"pbRate":"3.93","psRate":"3.68","week52High":216.752,"institutionHeld":0,"latestPrice":169.7,"committee":0.590909,"eps":-7.485836377806663,"divideRate":0.024076,"volume":159436,"delay":0,"ttmEps":-7.485836377806663,"open":166.47,"prevYearClose":168.21,"prevWeekClose":167.1,"prevMonthClose":169.351,"prevQuarterClose":113.256,"fiveDayClose":170.94,"twentyDayClose":132.859,"sixtyDayClose":111.42,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667636275","title":"CitiFirst CSL Instalments Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636275?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:32","pubTimestamp":1789345953,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260914:nASX9H7YgV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nASXcdLQt8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7511","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666052514","title":"CSL Seqirus Publishes Phase 3 Study Results for Influenza Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666052514","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666052514?lang=en_us&edition=fundamental","pubTime":"2026-09-11 08:52","pubTimestamp":1789087944,"startTime":"0","endTime":"0","summary":"CSL's  CSL Seqirus unit disclosed publication of pivotal phase 3 study results for its MF59-adjuvanted cell-based higher-dose quadrivalent influenza vaccine  for influenza prevention in older adults in The Lancet Infectious Diseases, according to a Friday statement.The phase 3 randomized immunogenicity and safety study enrolled 7,699 adults aged 50 and older across eight countries and compared aQIVc with two enhanced influenza vaccines, demonstrating superiority versus the adjuvanted egg-based influenza vaccine comparator across all four influenza strains and age groups, and non-inferiority versus a recombinant influenza vaccine for three out of four strains in the 50-plus age group and four out of four strains in those aged 65 and older, the company said.The study also demonstrated immune responses that persisted throughout the influenza season and a well-tolerated safety profile, with most reactions mild or moderate and resolving within three days, CSL added.The study authors conclud","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7511","CSL.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031153","title":"Australia's CSL Slips on Trading Ex-Dividend, Among Benchmark's Top Percentage Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031153?lang=en_us&edition=fundamental","pubTime":"2026-09-09 08:15","pubTimestamp":1788912921,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL slips on trading ex-dividend, among benchmark's top percentage losers** Shares of CSLCSL.AXfall as much as2.7% to A$170.01, their lowest level since Aug 24** Shares of pharmaceutical giant post biggest intraday pct drop since Aug 21** Shares trade ex-dividend;declaredfinal dividend of $1.62 per share in August** Co among top percentage losers in Australia's S&P/ASX 200 index.AXJO, which is up 0.2%** YTD, shares down 0.6%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4N45100G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7508","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665343747","title":"CitiFirst CSL SFIs Dividend Estimated Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2665343747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665343747?lang=en_us&edition=fundamental","pubTime":"2026-09-08 08:12","pubTimestamp":1788826355,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260908:nASXLBQ8s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nASX4xnJYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138693","title":"CSL Says Vanguard Group Raises Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138693","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138693?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:58","pubTimestamp":1788494293,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said Vanguard Group raised its voting power in the firm to 7.001% as of Aug. 31 from 6% previously, according to a Friday Australian bourse filing.Vanguard holds 33.5 million ordinary shares in the firm as of Aug. 31, per the filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282421","title":"Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282421?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:13","pubTimestamp":1788419596,"startTime":"0","endTime":"0","summary":"Australian shares rise as miners, banks gain on lower oil, bond yieldsSept 3 (Reuters)-Australian shares rebounded from a one-month low on Thursday, led by heavyweight banks, as easing oil prices and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572940350.SGD","IE00BWDBJ516.SGD","LU0264606111.USD","LU0654597011.USD","LU0831103253.SGD","IE0034235071.USD","LU0266512473.USD","LU0345777659.USD","BK7501","LU0612318971.USD","RIO.UK","LU1130305938.SGD","LU0572939691.SGD","LU0612318385.USD","BK7507","BK7095","LU0505663152.USD","LU0075056555.USD","LU0955648018.USD","LU0955669360.SGD","LU0011963245.USD","BHP.AU","BK7142","IE00B3M56506.USD","LU0161305163.EUR","BK7067","BK7511","LU0955623706.USD","BK5111","LU1064927863.SGD","CSL.AU","LU1078025761.USD","BK7007","LU1430597077.USD","SG9999001143.SGD","LU0345781412.USD","COH.AU","LU1302929846.USD","LU0971552673.USD","LU0456854461.SGD","LU0971552830.HKD","IE00BQJZX424.USD","LU0171293334.USD","LU0788109121.HKD","LU1046248800.SGD","STO.AU","LU0330918003.SGD","BK7508","LU1481600234.SGD","LU0345780950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664426518","title":"Black Box Warning on CSL's Injectafer Unlikely to Change Much","url":"https://stock-news.laohu8.com/highlight/detail?id=2664426518","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664426518?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:34","pubTimestamp":1788392040,"startTime":"0","endTime":"0","summary":"2329 GMT [Dow Jones]--The addition of a black box warning to the label of CSL's Injectafer is unlikely to have a big impact, according to Citi. The Food and Drug Administration approved revised labeling for the iron replacement medicine to warn of the risk of low levels of phosphate in the blood. \"We do not think it will change much,\" says Citi. \"Generics to Injectafer have become available over the last few weeks and, per FDA, are expected to update their labels also.\" Citi has a neutral rating and A$160/share target on CSL. The stock ended Wednesday at A$173.85.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664918898","title":"CSL Bulls Don't See Large Impact from U.S. Pricing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664918898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664918898?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:29","pubTimestamp":1788316140,"startTime":"0","endTime":"0","summary":"0229 GMT - CSL's bulls at UBS don't think the Australia-based pharmaceutical company will experience much of a direct financial impact from its U.S. pricing agreements. CSL has agreed to give Medicaid access to medicines at prices comparable to those in other developed economies, but the investment bank's analysts point out that the state-based program accounts for a relatively small part of its U.S. sales. On top of that, they don't see obligations around the pricing of future drug launches as onerous, given that CSL will be in control of settings and able to manage the impact in its best interests. UBS has a last-published buy rating on the stock and a target price of 181.00 Australian dollars. Shares are up 0.5% at A$173.12.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","BMY","IE00BKVL7J92.USD","LU2111349929.HKD","LU1894683348.USD","LU1221951046.USD","LU1718418525.SGD","LU2087625088.SGD","IE00BLSP4452.SGD","LU1074936037.SGD","LU2403377893.USD","SG9999018865.SGD","SG9999017495.SGD","NVS","LU2108987350.USD","LU2552382132.HKD","LU1066053197.SGD","LU2471134952.CNY","LU2360106947.USD","LU0661504455.SGD","LU1989772923.USD","LU1712237335.SGD","SG9999014914.USD","LU0072461881.USD","LU2756315318.SGD","LU1988902786.USD","BK4533","LU0124676726.USD","BK4588","LU2028103732.USD","LU2347655156.SGD","BK7067","MEDI","LU0238689110.USD","IE0002141913.USD","LU0154236417.USD","LU0321505439.SGD","LU1974910355.USD","LU0943347566.SGD","NVO","LU1059921491.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B4JS1V06.HKD","IE00BFXG1179.USD","LU2023250843.SGD","04332","LU1232071149.USD","LU0158827781.USD","LU0162691827.USD","LU0234572021.USD","IE00BK4W5L77.USD","LU1267930490.SGD","SG9999014880.SGD","SG9999014559.SGD","IE00B19Z3581.USD","LU1116320737.USD","IE00BKPKM429.USD","BK4585","LU0965509101.SGD","LU1127390331.HKD","HRTS","LU0417517546.SGD","IE00BFSS8Q28.SGD","BMED","LU0345769631.USD","LU0994945656.USD","LU0787776722.HKD","LU0511384066.AUD","IE000MB6IJN5.SGD","LU1228905540.USD","LU1868837300.USD","LU2087621335.USD","LU2133065610.SGD","SGXZ31699556.SGD","IBB","LU0949170772.SGD","LU2324357040.USD","LU1979441026.SGD","LU2360032135.SGD","AZN","LU1066051225.USD","BK4566","IE000SO60NU8.SGD","LU1244550221.USD","LU0965508806.USD","LU1778281490.HKD","LU0306806265.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0545562505.USD","IE000F7OJYX1.SGD","SGXZ99366536.SGD","SG9999014542.SGD","IE0009355771.USD","LU1267930813.SGD","BIB","LU0203347892.USD","XLV","LU0256863811.USD","RXL","GSK","LU0109394709.USD","LU2362541273.HKD","SGXZ80539844.SGD","LU2596442595.SGD","SGXZ57979304.SGD","LU2750360641.GBP","SG9999011175.SGD","SG9999015358.SGD","LU1280957306.USD","IE00B7SZLL34.SGD","LU0094547139.USD","LU0820561909.HKD","PFE","LU0158827948.USD","LU0708995401.HKD","LU1868837136.USD","IE0000B7K699.USD","LU0079474960.USD","LU1035775433.USD","LU0738911758.USD","SG9999002224.SGD","LU0316494557.USD","LU0267386448.USD","LU0882574055.USD","LU0640476718.USD","LU0820562030.AUD","LU1804176565.USD","BK4599","LU0320765489.SGD","LU1244550577.SGD","BBH","LU2357627491.SGD","LU0868494708.USD","MRK","LU1674673428.USD","NVOC","IE00BN8TJ469.HKD","LU0097036916.USD","LU0354030438.USD","LU2125909593.SGD","LU1720051108.HKD","LU0170899867.USD","LU0964807845.USD","LU0820561818.USD","LU1037948897.HKD","NVOH","LU2211815571.USD","LU1066051811.HKD","LU1732799900.SGD","LU2112291526.USD","LU2462157665.USD","LU1093756168.USD","LU0061475181.USD","LU0689626769.HKD","LU0320765646.SGD","IE00BJLML261.HKD","LU0211327993.USD","LU2347655073.USD","BK4516","LU0912757837.SGD","LU1366192091.USD","LU2505996681.GBP","SG9999014575.USD","LU0310799852.SGD","LU2264538146.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1003077747.HKD","LU0965509283.SGD","LU0211331839.USD","LU1496350171.SGD","LU1670710661.SGD","FHLC","LU1066051498.USD","THNR","LU1196500208.SGD","LU1244550494.USD","LU0225771236.USD","FTXH","MHIP","IE00BFSS7M15.SGD","LU0265550946.USD","CURE","LU1093756325.SGD","LU1670710588.SGD","LU2461242641.AUD","LU1868836914.USD","LU2491050071.SGD","LU0795875169.SGD","LU1228905037.USD","LU1934455194.USD","LU1267930730.SGD","BK0239","REGN","LU0466842654.USD","LU0859254822.USD","LU2468319806.SGD","BK4007","LU0234570918.USD","IE00BJJMRX11.SGD","LU2023251221.USD","LU1064131342.USD","LU1914381329.SGD","LU2237438978.USD","LU0069063385.USD","LU0889566641.SGD","LU0553294199.USD","LU2756315664.SGD","GILD","IE0004445239.USD","LU0174119429.USD","LU1670711040.USD","LU1236620834.HKD","LU1989771016.USD","LU0868494617.USD","IXJ","TRUH","LU1236620750.USD","LU2487616109.SGD","AZNH","LU0889565916.HKD","LU1116320901.HKD","IE0004445015.USD","IE00BVYPNV92.GBP","LU0708994859.HKD","IE00B7KXQ091.USD","IE0034235303.USD","LU1934455277.USD","LU0471298694.HKD","LU2089283258.USD","LU0130517989.USD","AMGN","LU1670711123.USD","LU1043141396.HKD","LU0029864427.USD","LU1551013342.USD","LU1670628061.USD","LU1868836591.USD","SG9999015986.USD","SG9999018857.SGD","LU0353189680.USD","LU2168564222.USD","LU1145028129.USD","SG9999013999.USD","BK4532","SG9999015952.SGD","IE000WAW04H5.SGD","IE00BWXC8680.SGD","LU0320765059.SGD","IE00BLSP4239.USD","LU2265009873.SGD","CSL.AU","BK4592","LU0980610538.SGD","LU0683600562.USD","LU2168564065.EUR","LU0114720955.EUR","LU2471134879.HKD","IYH","LU2746668974.SGD","LU1623119135.USD","AGNG","LU0130102774.USD","LU0385154629.USD","LU1221951129.SGD","GSK.UK","LU0426412945.USD","LU0823434740.USD","LU0058720904.USD","LU2746668461.USD","LU0098860793.USD","LU2462591350.SGD","LU2089984988.USD","LU0225284248.USD","LU2242652126.USD","LLY","688235","IE00B1XK9C88.USD","LU2168563687.JPY","LU1629891620.HKD","LU0471298777.SGD","LU2089284900.SGD","SG9999003800.SGD","LU1037948541.HKD","LU2552382215.SGD","BK7501","TBXU","LU1934455863.HKD","IE00BN29S564.USD","LU0006306889.USD","LU0792757196.USD","LU0823416689.USD","LU0726765562.USD","BK4504","LU1323610961.USD","LU1032955483.USD","LU2271345857.HKD","LLYX","LU1506573853.SGD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU0345769128.USD","LU0942090050.USD","TMED","LU1829250122.USD","SGXZ51526630.SGD","SG9999014567.USD","06160","IE00BJJMRY28.SGD","LU1032466523.USD","LU1261432733.SGD","LU2168564149.EUR","LU2125154778.USD","LU0353189763.USD","LU0395794307.EUR","OZEM","LU2362540622.SGD","LU0070302665.USD","IE00BBT3K403.USD","LU0472753341.HKD","SG9999015945.SGD","LU0265550359.USD","LU0096364046.USD","LU0256863902.USD","LU2168564495.EUR","IHE","LU1035773651.USD","LU1069344957.HKD","LU2505996509.AUD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU1699723380.USD","WDNA","LU1496350502.SGD","SG9999001176.SGD","PAWZ","LU1814569148.SGD","VHT","LU1917777945.USD","LU2213496289.HKD","SG9999001176.USD","IE00B775H168.HKD","BK4139","LU0237698245.USD","SG9999014906.USD","BK4578","LU2129689605.HKD","LU2417539215.USD","GDOC","LU0672654240.SGD","LU0266013472.USD","LU1043141123.HKD","LU1989772840.SGD","LU2433249047.HKD","LU0203202063.USD","PBE","IE00B3PB1722.GBP","LU1941712264.USD","LLYZ","LU0456855351.SGD","CANC","LU0648001328.SGD","BK7508","BK7511","LU2491049909.HKD","LU1894683264.USD","LLII","LU0965509010.AUD","LU0203201768.USD","IE0001KFT4U8.USD","LU1983299246.USD","LU0128525929.USD","BBIO","LU2237443549.SGD","LU2602419157.SGD","LU2361044865.SGD","LU2357305700.SGD","LU0310800379.SGD","ELIS","IE0002270589.USD","LU1941712348.USD","LU2471134523.USD","JDOC","BK4581","GLAM","LU2592432038.USD","PJP","LU0545039389.USD","LU2129689514.USD","IE000M9KFDE8.USD","LU2125154935.USD","LU0786609619.USD","LU0861579265.USD","PPH","SG9999015978.USD","LU1691799644.USD","LU0106261372.USD","LU0795875086.SGD","LU1732800096.USD","LU1839511570.USD","LU0426417589.USD","LU1674673691.USD","LU0345770993.USD","LU2237443622.USD","LU0109391861.USD","LU2362541513.USD","SG9999002232.USD","LU2242646821.SGD","MEDX","SG9999001440.SGD","LU0070217475.USD","IE0005OL40V9.USD","LU0306807586.USD","IE00BSNM7G36.USD","ONC","LU2237443895.HKD","LU0211328371.USD","LU2430703095.HKD","LU0198837287.USD","LU2896262040.SGD","LU0203345920.USD","LU2129689431.USD","LU2456880835.USD","LU0289739343.SGD","IE00BK4W5M84.HKD","LU1121112475.USD","BK4505","IE00B42XCP33.USD","ELIL","IE00BDGV0183.EUR","LU0985320562.USD","LU0882574139.USD","IE00B3T34201.USD","LU0323591593.USD","LU1061106388.HKD","SG9999014898.SGD","IE00BKDWB100.SGD","SGXZ81514606.USD","LU0208291251.USD","NVOX","LU2750360997.AUD","LU2361044949.HKD","LU1670627923.USD","LU2361045086.USD","LU0133085943.USD","LU2430703178.SGD","ILDR","LU2471134796.USD","LU1571399168.USD","ABBV","LU1923622614.USD","BK4559","BK4550","IE00BFTCPJ56.SGD","LU0689472784.USD","LU0345770308.USD","LU0210528500.USD","LU2491050154.USD","LU0122379950.USD","JNJ","LU0985481810.HKD","LU1551013425.SGD","IBBQ","LU0477156953.USD","LU0321505868.SGD","LU0057025933.USD","LU0320765992.SGD","LU1585245621.USD","BK4583","LU1935042991.SGD","LU0354030511.USD","LU1929549753.HKD","LU2430703251.USD","LU0289961442.SGD","LU2552382058.USD","BK4568","LU0225283273.USD","LU2236285917.USD","LU0432979614.USD","LU1883839398.USD","LU1548497426.USD","GSKH","LU2023250330.USD","LU1720051017.SGD","LU2125909247.SGD","SG9999015341.SGD","LU2063271972.USD","LU2237443978.SGD","LU2237443382.USD","BK4534","LU1868836757.USD","GB00BDT5M118.USD","LU0823434583.USD","LU2023250504.SGD","LU2106854487.HKD","LU1069347547.HKD","LU0210536198.USD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0053666078.USD","LU1162221912.USD","LU1291159041.SGD","LU1267930573.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887889","title":"CSL's U.S. Agreements Remove Two Stock Overhangs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887889","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887889?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:22","pubTimestamp":1788229320,"startTime":"0","endTime":"0","summary":"0222 GMT - CSL's U.S. agreements on drug pricing and manufacturing expansion remove two overhangs on the stock, Morgans analyst Derek Jellinek says. He tells clients in a note that the Australia-based pharmaceutical company has reinforced its competitive position as a major U.S. manufacturer of plasma-derived therapies. Jellinek sees the key positive of CSL's Medicaid pricing agreement as the improved visibility on exposure to potential U.S. drug-pricing reform. As for its onshoring agreement, he reckons it gives greater certainty with regard to tariff exposure. Morgans has a last-published buy rating on the stock and a target price of 187.71 Australian dollars. Shares are up 0.9% at A$173.07.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","CSL.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899648","title":"ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899648","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899648?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:12","pubTimestamp":1788221579,"startTime":"0","endTime":"0","summary":"Australian shares are poised to fall on Tuesday as oil prices surged more than 2.5% after renewed US-Iran military action heightened concerns over global supply disruptions and a prolonged conflict.Ov","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IOZ.AU","BBOZ.AU","BK7511","QFN.AU","VAS.AU","CSL.AU","BK7104","STW.AU","BEAR.AU","OZR.AU","IMLC.AU","OZF.AU","IIGF.AU","XKO.AU","XJO.AU","DACE.AU","E200.AU","QRE.AU","IISV.AU","XAO.AU","GEAR.AU","BK7508","VAP.AU","BK7067","EIGA.AU","ZYAU.AU","SLF.AU","GIVE.AU","BK7501","AUC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886424","title":"CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886424","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886424?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:29","pubTimestamp":1788218965,"startTime":"0","endTime":"0","summary":"CSL  has entered agreements with the US Administration to lower medicine costs and expand its manufacturing footprint in the US, according to a Tuesday Australian bourse filing.The company will provide Medicaid access to its medicines at prices comparable to those in other developed countries and extend similar pricing to newly launched therapies for all US payers under an agreement with the US Department of Health and Human Services, per the filing.The company has also entered into an onshoring agreement with the US Department of Commerce for its planned $1.5 billion expansion in Kankakee, Illinois, aimed at increasing production of plasma-derived therapies, the filing said.The company said the agreements are not expected to materially affect fiscal 2027 financial results, while providing greater certainty over US drug pricing and potential Section 232 tariff exposure, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7511","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033885","title":"CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033885","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:28","pubTimestamp":1788215330,"startTime":"0","endTime":"0","summary":"CSL signs U.S. government agreements to lower drug prices for MedicaidCSL signed agreements with the US government to lower US drug prices, including Medicaid pricing comparable to other developed cou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbfGxJ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CSL.AU","BK7511","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852458","title":"CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664852458?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:17","pubTimestamp":1788214638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE3CPQVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0046","BBIO","LU0889565916.HKD","688235","IE00BJT1NW94.SGD","AMGN","TBXU","LU1883839398.USD","BK4505","300485","IE0002270589.USD","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0320765992.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","BK4566","LU0306806265.USD","LU0868494617.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","BK4534","OZEM","PFE","CSL.AU","BBH","BK0028","IBB","PJP","BK0012","SG9999002224.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK7511","LU0109394709.USD","IONS","LU2468319806.SGD","IE00B3T34201.USD","BK4550","LU1983299246.USD","LU1894683348.USD","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE0002141913.USD","BK4007","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664701000","title":"CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois","url":"https://stock-news.laohu8.com/highlight/detail?id=2664701000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664701000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7511","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664400070","title":"CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664400070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664400070?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664082000","title":"CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664082000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664082000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7508","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007000","title":"CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7511","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000920","title":"CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000920?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7508","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}